[Publishing orders] The market is ups and downs, did your options make or lose?

Futubull Options Sir

joined discussion · ·

Earnings and Options Strategy | The Critical Battle Against SpaceX! Rocket Lab's Earnings Release Looms, Can the Neutron Rocket Achieve Its First Launch in Q4 2026?

$Rocket Lab (RKLB.US)$ Scheduled to release earnings after market close on May 7th Eastern Time, institutional forecasts expect the company to achieve revenue of $189 million in Q1 2026, a year-over-year increase of 54.53%; estimated earnings per share at -$0.079, with losses narrowing by 34.42% year-over-year. The above data is based on US-GAAP accounting standards.

As the leading operator of the Electron small launch vehicle, the company is accelerating its transition to the medium-lift Neutron while achieving vertical integration and stable cash flow through its Space Systems business.

Wall Street's core expectations for this earnings report go beyond the specific numbers, focusing more on Neutron progress, gross margin resilience, backlog conversion, and cash burn rate.These factors will directly impact investors' confidence in the company’s transformation narrative from a medium-lift rocket player to a 'SpaceX alternative.'

Top catalyst: Progress of the Neutron heavy-lift rocket – Can the target of a Q4 2026 maiden flight be maintained?

If the Electron small rocket is Rocket Lab’s cash cow, then the Neutron rocket is the company’s core ace to break through industry ceilings and compete with SpaceX’s Falcon 9, as well as the top catalyst for this earnings report.

Neutron is a 43-meter-long partially reusable medium-lift launch vehicle, primarily positioned to fill the market gap between small satellite launches and large heavy-load launches. It focuses on commercial satellite deployment, government payloads, and cargo missions. Once successful, it will elevate Rocket Lab from a 'small launch service provider' to a 'full-spectrum aerospace solutions provider.'

However, the project has not been without challenges. Previously, due to a rupture during Stage 1 propellant tank testing (caused by manufacturing defects from hand-laid processes), the company has postponed the first launch window to Q4 2026 through early 2027.

During this earnings call, the market will focus on three core questions:

First isWhether the Q4 2026 maiden flight target is secure, and whether there is a risk of further delays;

Second,Progress in manufacturing process improvements, whether critical tests have been passed after automated fiber placement replaced manual processes;

Third isPlanning for subsequent R&D milestones, including the schedule for key milestones such as ground testing, rocket body assembly, and launch site debugging.

Institutions such as Goldman Sachs have pointed out that every quarter of delay for Neutron will directly reduce the company’s revenue expectations for 2027-2028 by 10%-15%.

The success of Neutron is crucial to the company's valuation.Once operational, Neutron’s per-launch revenue and reusability will be significantly higher than Electron’s, opening up a higher gross margin space. However, aerospace R&D inherently carries high risks, and similar rocket projects in history often experience multiple delays. If management signals any postponement or if test data falls short of expectations, the stock price may face downward pressure. Conversely, clear progress will reinforce the narrative of 'scaled launches by 2027,' becoming a major positive catalyst.

Basic financial health: Gross margin, order conversion, and cash flow under high R&D investment

As Neutron R&D enters its peak period, the stability of gross margins, the efficiency of converting backlog orders, and the balance between cash flow and R&D spending have become core indicators for assessing the company’s ability to balance growth and profitability under sustained high-intensity investment.

In the Q1 earnings report, the market will focus on:

– Gross margin trend：

The company's full-year GAAP gross margin for 2025 is 34.4%, while the non-GAAP gross margin in the fourth quarter rose to 44.3%, primarily benefiting from the scaling up of launch operations and the increased proportion of high-margin Space Systems business. For the first quarter of 2026, the company provided clear guidance: GAAP gross margin of 34%-36%, and non-GAAP gross margin of 39%-41%.

The market's core focus is on whether the company can maintain the gross margin floor during the peak period of Neutron R&D spending (Q1 may mark the peak of R&D expenditure), or even achieve structural improvements.

– Backlog conversion：

Rocket Lab’s full-year revenue for 2025 reached $602 million, a year-on-year increase of 38%, with a record backlog of $1.85 billion, growing by 73% year-on-year. This includes an $816 million mega-order from the U.S. Space Development Agency. Management expects about 37% of the backlog to convert into revenue in 2026, providing visibility for the full-year performance.

However, having orders on hand does not equate to revenue realization. Investors will closely track order conversion efficiency in this earnings report: first, the value of new orders in Q1 to verify whether market demand remains robust; second, the proportion of carried-over backlog converted into revenue, particularly the delivery progress of high-margin space systems orders; third, the payment schedule of government orders, assessing whether it meets expectations and whether there are any risks of delay.

– Cash flow and R&D expenditure：

Neutron R&D is a capital-intensive project, and Q1 2026 is widely considered by the market as the peak quarter for R&D expenditure. In 2025, the company’s net operating cash flow was -$166 million, and net cash flow from investing activities was -$347 million.

In this earnings report, two key cash flow metrics will be critical: first, free cash flow guidance; second, the burn rate, which refers to average monthly cash outflow. Investors need to assess whether the current cash reserves (standing at $1.071 billion as of the end of 2025) are sufficient to cover up to the Neutron’s inaugural launch and whether additional financing is required. If the Q1 cash flow loss is smaller than expected and a clear timeline for positive cash flow conversion is provided, it will significantly boost market confidence.

Other catalysts: M&A integration progress and new products

Over the past two years, Rocket Lab has completed multiple strategic acquisitions, focusing on three high-value sectors: laser communications, EO/IR sensors, and precision components. Notable targets include Mynaric and Geost.

On April 14, 2026, the company completed the acquisition of Mynaric, a German laser communication terminal supplier, for $1.553 billion, higher than the original agreed price. In this earnings report, the market will focus on the progress of integrating the acquired assets, such as whether Mynaric's laser communication equipment has secured new orders.

Leveraging both acquisition integration and in-house R&D capabilities, Rocket Lab has recently launched several high value-added new products, among which the High-Performance Star Tracker has drawn the most market attention. Investors will focus on the contract execution and commercialization timeline for this product. Additionally, updates on new products in areas such as hypersonic testing and small satellite platforms could become incremental highlights during the earnings call, further expanding growth potential.

Institutional views and technical analysis

The current consensus rating from analysts is 'Strong Buy,' with an average target price of $91.1, indicating significant upside potential from the current price. Since April, multiple institutions have raised their target prices; for instance, Stifel increased its target price from $90 to $105, expecting the Neutron project to proceed as planned.

From a technical perspective, the stock maintains a solid long-term bullish structure, with the share price fluctuating above the 200-day moving average. The short-term pullback remains above key support levels at the 30-day and 60-day moving averages, indicating a high probability of stabilization. Attention should be paid to whether the company can hold the critical support level between $72-$74 post-earnings. If it holds and sees volume-driven recovery above the 10-day moving average at $82, there is a high likelihood of resuming the uptrend. Conversely, breaking below would signal weakness, with downside support seen at the 200-day moving average around $62.

Options strategy: Trading strategy under 13% expected volatility

Ahead of Rocket Lab’s earnings report, the implied volatility (IV) percentile stands at 49%, suggesting relatively low option IV. Purchasing calls currently offers an advantage, but high post-earnings volatility is anticipated. Option pricing implies a bidirectional price swing of 13.16% after the report, reflecting the market’s unanimous view of 'high uncertainty' surrounding this earnings release.

Investors with different risk appetites may consider the following structured strategies (not investment advice, for reference only):

1. Call option spread (moderately bullish)

If investors are optimistic about Neutron's progress and order conversion, they can buy a Call option with a lower strike price while selling a Call option with a higher strike price, resulting in a net outlay of premium. The maximum profit is limited, but costs are controllable; if positive catalysts drive the stock price up, decent returns can be achieved. The risk lies in losing the net premium paid.

(The images displayed on the screen are for demonstration purposes only and do not constitute any investment advice or guarantee; market conditions fluctuate frequently, and the illustrated option prices do not represent real-world values.)

2、Buying Put (Defensive Bearish)：

If investors are concerned about potential delays with Neutron, margin pressure, or orders falling short of expectations, they can buy Put options as 'insurance' for their existing holdings.

3. Covered Call

Long-term holders with existing stock positions may considerselling out-of-the-money Call optionsto collect premiums that hedge downside risk, while also being able to sell the stock for profit if the share price rises to the strike price. This strategy suits investors who believe in Neutron’s long-term certainty but anticipate significant short-term volatility.

4. Straddle (neutral volatility strategy)：

Simultaneously buying a Call and Put with the same expiration date and strike price is suitable for scenarios anticipating significant volatility but uncertain direction. Profit can be made if Neutron's update exceeds or falls short of expectations, causing a sharp stock price reaction. However, if the stock price moves within a narrow range, premiums on both options will be lost, and the risk of implied volatility (IV) crush should be noted.

(The image displayed on the screen is for illustrative purposes only and does not constitute any investment advice or guarantee; market conditions fluctuate frequently, and the option prices shown do not represent real-world values.)

Summary

This Q1 2026 earnings report is a critical battle for Rocket Lab. The progress of Neutron will determine whether the growth thesis holds, gross margins and cash flow will verify the baseline of financial health, and the ability to deliver results will decide whether high valuations can be sustained.

Fellow investors, do you think Rocket Lab’s stock could kick off an upward trend after its earnings report, before SpaceX goes public?

‘Earnings Express’ - AI insights into key points; build an options strategy in three steps!

Disclaimer

This content does not constitute any offer, solicitation, recommendation, opinion, or guarantee for any securities, financial products, or instruments. The risk of loss in trading options can be substantial. In some cases, your losses may exceed the initial margin amount deposited. Even if you have set contingent orders, such as 'stop-loss' or 'limit' orders, they may not necessarily prevent losses. Market conditions may render these orders unexecutable. You may be required to deposit additional margin within a short period. If you fail to provide the required amount within the specified time, your open positions may be liquidated. However, you will still be responsible for any deficit balance in your account. Therefore, before trading, you should study and understand options and carefully consider whether such trading is suitable for you based on your financial situation and investment objectives. If you trade options, you should be familiar with the procedures upon exercising options and at expiration, as well as your rights and obligations when exercising options and at expiration.

Editor/Doris

149K Views